Should biomarkers [and Pharma] drive Alzheimer’s diagnosis?
This news item by Alicia Ault was published in Medscape, 27 January 2025:
Tag: Alzheimers
The Myth of Unbiased Medical Education
In a recent blog I shared promotional material hosted by the BMJ. This material included videos of a symposium held at the Royal Society of Medicine: The Royal Society of … Continue reading The Myth of Unbiased Medical Education
Following the sunrise
On The BMJ home page I came across this advert by Eli Lilly. It invited me to “Learn how to better identify early signs of Alzheimer’s Disease” and warned that … Continue reading Following the sunrise
Light breaks where no sun shines
On The BMJ home page I came across this advert by Eli Lilly. It invited me to “Learn how to better identify early signs of Alzheimer’s Disease” and warned that … Continue reading Light breaks where no sun shines
‘Left wondering’
This rapid response by Shirley Nurock was made in response to a BMJ report that the US drug company Biogen is “walking away from its Alzheimer’s drug aducanumab (Aduhelm).” In … Continue reading ‘Left wondering’
I write as ‘one of those’.
The following response was written by myself over a decade ago. The recent extensive promotion of Scottish Brain Sciences reminded me of it. Response to the head to head debate: … Continue reading I write as ‘one of those’.
Anti-amyloid drugs: Key questions
As published here.
Accelerated approval of anti-amyloid drugs
I fully share the concerns expressed by Professor Robert Howard: